Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | tissue type plasminogen activator | 0.0625 | 0.8393 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0625 | 0.8393 | 0.8393 |
Onchocerca volvulus | 0.0613 | 0.8071 | 0.8071 | |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0625 | 0.8393 | 0.8393 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0625 | 0.8393 | 0.5 |
Brugia malayi | SEA domain containing protein | 0.0613 | 0.8071 | 0.8071 |
Loa Loa (eye worm) | hypothetical protein | 0.0687 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0625 | 0.8393 | 0.8393 |
Loa Loa (eye worm) | hypothetical protein | 0.0613 | 0.8071 | 0.8071 |
Onchocerca volvulus | 0.0613 | 0.8071 | 0.8071 | |
Schistosoma mansoni | hypothetical protein | 0.0625 | 0.8393 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0625 | 0.8393 | 0.5 |
Onchocerca volvulus | 0.0613 | 0.8071 | 0.8071 | |
Toxoplasma gondii | kringle domain-containing protein | 0.0625 | 0.8393 | 0.5 |
Onchocerca volvulus | 0.0613 | 0.8071 | 0.8071 | |
Onchocerca volvulus | 0.0687 | 1 | 1 | |
Loa Loa (eye worm) | DOMON domain-containing protein | 0.0613 | 0.8071 | 0.8071 |
Onchocerca volvulus | 0.0625 | 0.8393 | 0.8393 | |
Schistosoma mansoni | hypothetical protein | 0.0613 | 0.8071 | 0.9508 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0625 | 0.8393 | 0.5 |
Brugia malayi | Kringle domain containing protein | 0.0625 | 0.8393 | 0.8393 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0625 | 0.8393 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0374 | 0.1801 | 0.1801 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0625 | 0.8393 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.